You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 245 No. 11, March 20, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (156)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Successful Treatment of Naturally Occurring Influenza A/USSR/77 H1N1

Lee P. Van Voris, MD; Robert F. Betts, MD; Frederick G. Hayden, MD; William A. Christmas, MD; R. Gordon Douglas, Jr, MD

JAMA. 1981;245(11):1128-1131.


Abstract

Forty-five university students with proved influenza A/USSR/77 H1N1 infection were randomly treated with either amantadine hydrochloride (14 students), rimantadine hydrochloride (19 students), or placebo (12 students). By 48 hours after initiation of therapy, amantadine and rimantadine recipients had significantly less fever and greater improvement compared with subjects given the placebo. Minor reversible CNS side effects at the end of the five-day course of therapy were observed in one third of the amantadine-treated subjects. However, both amantadine and rimantadine recipients returned to classes earlier and shed smaller amounts of virus than placebo recipients. Thus, both drugs exerted a notable therapeutic effect. Hence, during an influenza outbreak, five days of empirical therapy with amantadine or rimantadine for persons with an influenza-like syndrome should ameliorate clinical symptoms and might decrease spread of virus.

(JAMA 1981;245:1128-1131)



Author Affiliations

From the Infectious Disease Unit, University of Rochester School of Medicine and Dentistry, Rochester, NY. Dr Van Voris is presently with the Department of Medicine, Section of Infectious Diseases, Marshall University School of Medicine, Huntington, WVa. Dr Hayden is currently with the Departments of Medicine and Pathology, Division of Epidemiology and Virology, University of Virginia School of Medicine, Charlottesville.


Footnotes

Reprint requests to Box MED, 601 Elmwood Ave, Rochester, NY 14642 (Dr Betts).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Development of an HTS Assay for the Search of Anti-influenza Agents Targeting the Interaction of Viral RNA with the NS1 Protein
Maroto et al.
J Biomol Screen 2008;13:581-590.
ABSTRACT  

Influenza: vaccination and treatment
Stephenson and Nicholson
Eur Respir J 2001;17:1282-1293.
ABSTRACT | FULL TEXT  

Principles of Appropriate Antibiotic Use for Treatment of Uncomplicated Acute Bronchitis: Background
Gonzales et al.
ANN INTERN MED 2001;134:521-529.
ABSTRACT | FULL TEXT  

Uncomplicated Acute Bronchitis
Gonzales and Sande
ANN INTERN MED 2000;133:981-991.
ABSTRACT | FULL TEXT  

Influenza: Prospects for Control
Couch
ANN INTERN MED 2000;133:992-998.
ABSTRACT | FULL TEXT  

Prevention and Treatment of Influenza
Couch
NEJM 2000;343:1778-1787.
FULL TEXT  

Influenza
Cifu and Levinson
JAMA 2000;284:2847-2849.
FULL TEXT  

Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza: A Randomized Controlled Trial
Treanor et al.
JAMA 2000;283:1016-1024.
ABSTRACT | FULL TEXT  

Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza: Randomized Controlled Trials for Prevention and Treatment
Hayden et al.
JAMA 1999;282:1240-1246.
ABSTRACT | FULL TEXT  

Chemotherapeutic control of influenza
Stephenson and Nicholson
J Antimicrob Chemother 1999;44:6-10.
FULL TEXT  

Antiviral Drugs
Balfour
NEJM 1999;340:1255-1268.
FULL TEXT  

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections
Hayden et al.
NEJM 1997;337:874-880.
ABSTRACT | FULL TEXT  

The Roles of Vaccination and Amantadine Prophylaxis in Controlling an Outbreak of Influenza A (H3N2) in a Nursing Home
Arden et al.
Arch Intern Med 1988;148:865-868.
ABSTRACT  

Toxic Shock Syndrome During an Influenza Outbreak
Sperber and Francis
JAMA 1987;257:1086-1087.
ABSTRACT  

Effectiveness of Rimantadine Prophylaxis of Children Within Families
Clover et al.
Arch Pediatr Adolesc Med 1986;140:706-709.
ABSTRACT  

Infectious Diseases: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
ANN INTERN MED 1982;97:938-943.
ABSTRACT  

Prevention of Influenza-Related Morbidity and Mortality
Glezen
Arch Intern Med 1982;142:25-26.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.